Clinical Trial Update: Tolvaptan for In-hospital Hyponatremia [Phase 2]

View source ↗

Summary

Phase 2 trial of tolvaptan for in-hospital hyponatremia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Samsca (tolvaptan)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Hyponatremia | Phase 2 | Status: TERMINATED